GRAIL, Inc. $GRAL Shares Acquired by Wesbanco Bank Inc.

Key Points

• Wesbanco Bank Inc. increased its stake in GRAIL, Inc. by 39.1% in Q2, owning 44,500 shares worth approximately $2.29 million.
• GRAIL, Inc. reported a quarterly loss of ($3.18) EPS, which was slightly below analysts' expectations, with revenue at $35.54 million against a forecast of $37.57 million.
• Insider trading activity included President Joshua J. Ofman selling 9,692 shares for $503,984, marking a 1.93% decrease in his holdings in the company.

Wesbanco Bank Inc. raised its holdings in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 39.1% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 44,500 shares of the company's stock after purchasing an additional 12,500 shares during the quarter. Wesbanco Bank Inc. owned approximately 0.12% of GRAIL worth $2,288,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. S.A. Mason LLC grew its stake in GRAIL by 50.1% in the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after acquiring an additional 500 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of GRAIL by 28.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock valued at $76,000 after purchasing an additional 623 shares during the last quarter. HighTower Advisors LLC grew its position in GRAIL by 5.7% during the 1st quarter. HighTower Advisors LLC now owns 11,591 shares of the company's stock worth $296,000 after acquiring an additional 627 shares during the last quarter. KBC Group NV grew its position in shares of GRAIL by 187.7% in the 1st quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after buying an additional 933 shares during the last quarter. Finally, Caldwell Sutter Capital Inc. acquired a new position in shares of GRAIL in the 1st quarter valued at about $28,000.

GRAIL Trading Up 4.8%

GRAL stock traded up $1.89 during trading on Friday, reaching $41.48. 343,716 shares of the stock were exchanged, compared to its average volume of 1,278,189. The firm has a market cap of $1.50 billion, a P/E ratio of -3.15 and a beta of 3.18. The firm's 50 day moving average is $35.32 and its 200 day moving average is $35.50. GRAIL, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing the consensus estimate of ($3.14) by ($0.04). The company had revenue of $35.54 million during the quarter, compared to analysts' expectations of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. As a group, analysts predict that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Insider Buying and Selling at GRAIL

In related news, CFO Aaron Freidin sold 8,000 shares of the stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer directly owned 286,020 shares of the company's stock, valued at $11,134,758.60. This represents a 2.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Chun R. Ding sold 339,800 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total transaction of $16,830,294.00. Following the transaction, the insider directly owned 3,305,055 shares of the company's stock, valued at approximately $163,699,374.15. This trade represents a 9.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold 361,694 shares of company stock valued at $17,780,266 in the last 90 days. Insiders own 1.85% of the company's stock.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.